23 06 14 extraordinary bm

Notice of Extraordinary General Meeting

The shareholders of CS MEDICA A/S (“CS MEDICA” or the “Company”) are hereby notified of an Extraordinary General Meeting that will be held on Friday the 30th of June 2023 at 15:00 at TEAMS. Shareholders will be entitled to vote by submitting postal vote forms prior to the meeting. Information about the resolutions passed at the meeting will be made public after the extraordinary general meeting has been held.

CS MEDICA is convening an Extraordinary General Meeting (EGM) to address changes within the company’s board.

Proposed agenda
1. Election of chairman of the meeting
2. Approval of new Board Member
3. Any other business.

— o —

Background Information for Approval of New Board Member
As part of the board’s evaluation and adaptation process to tackle emerging challenges, Alexandre Fevre will be stepping down, while Karsten Adelmark will assume a position on the board to address the changes within the company’s board.

Karsten Adelmark’s appointment aims to bolster CS MEDICA’s growth plans with strong financial and business expertise and experience, among others board experience, strong IT track record, and value-based leadership.

Current and former positions of Karsten Adelmark:

Wolmer Gruppen
• Chairman of the Board

• MD and member of the board

Cybercom Consulting
• CFO & Sales, MD and member of the board

• CFO and member of the board

• CFO and member of the board

Ernst & Young
• Accountant and Team manager

The EGM marks an important step in CS MEDICA’s commitment to evolving and strengthening its Board and leadership to better navigate the ever-changing healthcare landscape.

The company extends its appreciation to Alex for his valuable contributions and wishes him success in his future endeavors.

— o —

Registration for the EGM
The registration date is the 23rd of June 2023. Only those who are shareholders on this date can participate and vote at the extraordinary general meeting.

To obtain access to the general meeting and thus be able to participate and vote at the general meeting, a shareholder must, no later than 2 days before the general meeting, request an admission card, cf. section 5.9 of the articles of association. Such a request must be made to Sanne Holte, e-mail sh@cs-medica.com. The request must be received no later than the 23th of June 2023, at 11.59 PM (CET). A shareholder also has the possibility of requesting an admission card for a proxy holder who attends the general meeting by meeting on behalf of the shareholder. The request must be made according to the same above guidelines. The shareholder must fill in and sign the proxy and postal voting form, enclosed as schedule 1 which can also be found on the Company’s website www.cs-medica.com. The proxy must bring the admission card and the original form to the general meeting.

The total number of votes as of the date of this notice is 12,322,635.  The board has already received 9.143.701 positive votes, corresponding to 74 %.

To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register. Such registration must be duly affected in the share register on the 23rd of June 2023 and the shareholders must therefore advise their nominees well in advance of such date.

The shareholders have the right to ask questions in relation to the issues on the agenda to be discussed at the general meeting. The questions can be made in writing before the general meeting or at the general meeting. The answer will – with the limitations that follow from the legislation – if possible be made at the general meeting or made available to the shareholders no later than two weeks after the general meeting.

All material mentioned in this notice can be obtained from Sanne Holte, e-mail sh@cs-medica.com. The material will only be forwarded by e-mail, and thus the e-mail address must be specified.


EGM – Date and time
June 30, 2023, from 15:00-16:00 p.m. CET

Registration for EGM  sh@cs-medica.com.

Power of Attorney
Schedule 1  >>

On behalf of the board of directors
Jørgen Flemming Ladefoged, Chairman

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish-based MedTech company operating globally within research, development, manufacturing, commercializing, and a part of the pharmaceutical industry. The company combines science and nature with the purpose of creating products for a better every day by using modern technology to research and utilize different compounds found in the cannabis plant. CS MEDICA offers efficient, safe OTC alternative treatments with CBD for autoimmune and stress-related disorders under the trademark CANNASEN® or own-label options.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com, and LinkedIn.